Rhythm Pharmaceuticals buy Morgan Stanley
Start price
11.07.25
/
50%
€74.50
Target price
11.07.26
€81.37
Performance (%)
10.07%
Price
12.09.25
€82.00
Summary
This prediction is currently active. The prediction currently has a performance of 10.07%. This prediction currently runs until 11.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -5.202% | -5.202% |
| iShares Core DAX® | 0.245% | -1.751% |
| iShares Nasdaq 100 | 1.694% | 0.633% |
| iShares Nikkei 225® | 3.771% | 2.653% |
| iShares S&P 500 | 1.432% | 1.748% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was given a new $95.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
75.21%
12.09.25
12.09.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24